The MAURO study: baseline characteristics and compliance with guidelines targets

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Quality Improvement Science

Background:

• The Multiple Intervention and Audit in Renal Diseases to Optimize Care (MAURO) study investigated a quality improvement intervention in 22 renal clinics.
• The intervention aimed to enhance adherence to guidelines for preventing chronic kidney disease (CKD) progression and cardiovascular (CV) complications.

Purpose of the Study:

• To assess the efficacy of a multimodal quality improvement intervention on CKD care.
• To determine if the intervention improved adherence to targets for blood pressure, sodium intake, proteinuria, dyslipidemia, anemia, and calcium-phosphate levels.
• To evaluate the intervention's impact on slowing CKD progression and preventing CV complications.

Main Methods:

• A cluster randomized controlled trial design was employed across 22 renal clinics.
• Clinics were randomized into an intervention group receiving a multimodal quality improvement strategy and a control group receiving standard care.
• Key surrogate indicators related to CKD management were measured to assess outcomes.

Main Results:

• Baseline blood pressure goals were unmet in a majority of patients, particularly those with proteinuria or diabetes.
• Inadequate use of diuretics and high sodium excretion were observed in hypertensive patients.
• Over 40% of patients had uncontrolled cholesterol levels, with suboptimal statin use.
• Obesity was prevalent, though smoking rates were low, with a notable proportion of patients having quit.

Conclusions:

• Management of modifiable risk factors for CKD progression and cardiovascular disease in the studied cohort requires substantial improvement.
• The findings highlight critical areas for intervention to optimize patient outcomes in renal disease care.